Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
J Neuromuscul Dis. 2018;5(2):193-203. doi: 10.3233/JND-170225.
Obtaining an adequate number of patients to conduct a natural history study for rare diseases such as Becker muscular dystrophy (BMD) is difficult.
The present study used data from Remudy, a national registry for neuromuscular diseases in Japan, to conduct a phenotypic analysis of BMD.
We analyzed Remudy data of participants with dystrophinopathy. All participants who were aged 17 and older and were ambulant at age 13 were included in this study. Participants were divided into two groups: those with BMD who were ambulant at age 17, and those with intermediate muscular dystrophy (IMD) who lost ambulation by age 17. Frequent mutations were analyzed by age at ambulation, cardiopulmonary function, and genotype. For clinical comparisons, participants who were administered steroids were excluded.
From July 2009 through September 2015, 192 participants had registered with Remudy. Mean participant age was 34.80±13.3 (range, 17-78) years, and 52.1% of participants were ambulant. Of the entire study population, 50.5% had cardiomyopathy and 35.9% had respiratory failure. Three participants required invasive ventilation and 30 required non-invasive ventilation. Nineteen of the 30 non-invasive ventilator users were part-time users. In total, 138 (71.9%) had BMD and 54 (28.1%) had IMD. The most frequent mutation was ex45_ex47del (36 participants). Among participants with frequent in-frame mutations, those with the ex45-49del mutation lost their ambulation earlier than those with the ex45_ex47del mutation. A total of 67 different exon deletions and duplications were identified in the study population.
We clarified the clinical phenotypes of Japanese patients with BMD/IMD using data from Remudy. Our results suggest that not only IMD but also BMD are associated with risk of respiratory dysfunction.
对于像贝克肌营养不良症(BMD)这样的罕见疾病,很难获得足够数量的患者来进行自然病史研究。
本研究利用日本神经肌肉疾病注册研究 Remudy 的数据,对 BMD 进行表型分析。
我们分析了 Remudy 中肌营养不良症患者的数据。所有年龄在 17 岁及以上且 13 岁时能行走的参与者均纳入本研究。参与者分为两组:17 岁时能行走的 BMD 组和 17 岁时丧失行走能力的中间型肌营养不良(IMD)组。根据行走年龄、心肺功能和基因型分析常见突变。为了进行临床比较,排除了接受类固醇治疗的参与者。
2009 年 7 月至 2015 年 9 月,共有 192 名参与者在 Remudy 注册。参与者的平均年龄为 34.80±13.3(范围,17-78)岁,52.1%的参与者能够行走。在整个研究人群中,50.5%患有心肌病,35.9%患有呼吸衰竭。有 3 名参与者需要有创通气,30 名需要无创通气。30 名无创通气使用者中有 19 名是兼职使用者。共有 138 名(71.9%)患有 BMD,54 名(28.1%)患有 IMD。最常见的突变是 ex45_ex47del(36 名参与者)。在有频繁框架内突变的参与者中,携带 ex45-49del 突变的参与者比携带 ex45_ex47del 突变的参与者更早丧失行走能力。在研究人群中总共鉴定出 67 种不同的外显子缺失和重复。
我们利用 Remudy 的数据阐明了日本 BMD/IMD 患者的临床表型。我们的结果表明,不仅 IMD,而且 BMD 都与呼吸功能障碍的风险相关。